Fluticasone Propionate-salmeterol Combination Adherence in Patients With Chronic Obstructive Pulmonary Disease (COPD)
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 11,060
- 主要终点
- Mean Number of Pharmacy Claims by Participants During the Post-Index Period
研究概览
简要总结
The specific aim of this study is to describe 1 year Advair dispensing rates for patients with COPD, and to measure the association between Advair adherence and healthcare utilization (e.g. emergency room visits and inpatient admissions, etc.). To compare the risk of a COPD exacerbation (moderate or severe) during a 3-month follow-up period between patients thqat are adherent versus those that are not.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 40 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
COPD
Patients with a diagnosis code of COPD
干预措施: fluticasone propionate/salmeterol xinafoate combination (Drug)
结局指标
主要结局
Mean Number of Pharmacy Claims by Participants During the Post-Index Period
时间窗: One Year
The mean number of pharmacy claims incurred by participants during the one-year post-index period was measured.
Mean Number of Healthcare Encounters Incurred by Participants During the Post-Index Period
时间窗: One Year
The mean number of outpatient office visits, inpatient visits, and emergency department visits incurred by participants during the one-year post-index period was measured.
次要结局
未报告次要终点